Literature DB >> 17261111

A checklist for medication compliance and persistence studies using retrospective databases.

Andrew M Peterson1, David P Nau, Joyce A Cramer, Josh Benner, Femida Gwadry-Sridhar, Michael Nichol.   

Abstract

The increasing number of retrospective database studies related to medication compliance and persistence (C&P), and the inherent variability within each, has created a need for improvement in the quality and consistency of medication C&P research. This article stems from the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) efforts to develop a checklist of items that should be either included, or at least considered, when a retrospective database analysis of medication compliance or persistence is undertaken. This consensus document outlines a systematic approach to designing or reviewing retrospective database studies of medication C&P. Included in this article are discussions on data sources, measures of C&P, results reporting, and even conflict of interests. If followed, this checklist should improve the consistency and quality of C&P analyses, which in turn will help providers and payers understand the impact of C&P on health outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 17261111     DOI: 10.1111/j.1524-4733.2006.00139.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  188 in total

1.  Evaluating the potential for primary care to serve as a mental health home for people with schizophrenia.

Authors:  Lexie R Grove; William J Olesiuk; Alan R Ellis; Jesse C Lichstein; C Annette DuBard; Joel F Farley; Carlos T Jackson; Christopher A Beadles; Joseph P Morrissey; Marisa Elena Domino
Journal:  Gen Hosp Psychiatry       Date:  2017-03-07       Impact factor: 3.238

Review 2.  Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review.

Authors:  Mary A De Vera; Vidula Bhole; Lindsay C Burns; Diane Lacaille
Journal:  Br J Clin Pharmacol       Date:  2014-10       Impact factor: 4.335

3.  Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors.

Authors:  S M Cadarette; D H Solomon; J N Katz; A R Patrick; M A Brookhart
Journal:  Osteoporos Int       Date:  2010-06-08       Impact factor: 4.507

4.  Methods to examine the impact of compliance to osteoporosis pharmacotherapy on fracture risk: systematic review and recommendations.

Authors:  Milica Nikitovic; Daniel H Solomon; Suzanne M Cadarette
Journal:  Ther Adv Chronic Dis       Date:  2010-11-01       Impact factor: 5.091

Review 5.  Measuring and improving adherence to osteoporosis pharmacotherapy.

Authors:  Suzanne M Cadarette; Andrea M Burden
Journal:  Curr Opin Rheumatol       Date:  2010-07       Impact factor: 5.006

6.  Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: a population-based study.

Authors:  J Blouin; A Dragomir; M Fredette; L-G Ste-Marie; J C Fernandes; S Perreault
Journal:  Osteoporos Int       Date:  2008-12-24       Impact factor: 4.507

7.  Pills and ills: methodological problems in pharmacological research.

Authors:  Zachary A Marcum; Jerry H Gurwitz; Cathleen Colón-Emeric; Joseph T Hanlon
Journal:  J Am Geriatr Soc       Date:  2015-04       Impact factor: 5.562

8.  The effect of chairside chronic disease screenings by oral health professionals on health care costs.

Authors:  Kamyar Nasseh; Barbara Greenberg; Marko Vujicic; Michael Glick
Journal:  Am J Public Health       Date:  2014-02-13       Impact factor: 9.308

9.  Patient characteristics associated with medication adherence.

Authors:  Sharon J Rolnick; Pamala A Pawloski; Brita D Hedblom; Stephen E Asche; Richard J Bruzek
Journal:  Clin Med Res       Date:  2013-04-11

10.  A comparison of confounding adjustment methods for assessment of asthma controller medication effectiveness.

Authors:  Lingling Li; William M Vollmer; Melissa G Butler; Pingsheng Wu; Elyse O Kharbanda; Ann Chen Wu
Journal:  Am J Epidemiol       Date:  2014-01-23       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.